NASDAQ:EKSO Ekso Bionics - EKSO Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ekso Bionics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.65 +0.11 (+7.14%) (As of 03/31/2023 03:09 PM ET) Add Compare Share Share Today's Range$1.60▼$1.6650-Day Range$1.35▼$1.8852-Week Range$1.03▼$2.95Volume47,006 shsAverage Volume32,766 shsMarket Capitalization$21.68 millionP/E RatioN/ADividend YieldN/APrice Target$9.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Ekso Bionics MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside453.8% Upside$9.00 Price TargetShort InterestHealthy0.43% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.27Based on 12 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.96 out of 5 starsMedical Sector655th out of 1,009 stocksGeneral Industrial Machinery, Industry4th out of 10 stocks 3.5 Analyst's Opinion Consensus RatingEkso Bionics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.00, Ekso Bionics has a forecasted upside of 453.8% from its current price of $1.63.Amount of Analyst CoverageEkso Bionics has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.43% of the float of Ekso Bionics has been sold short.Short Interest Ratio / Days to CoverEkso Bionics has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ekso Bionics has recently increased by 1.87%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldEkso Bionics does not currently pay a dividend.Dividend GrowthEkso Bionics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EKSO. Previous Next 2.9 News and Social Media Coverage News SentimentEkso Bionics has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Ekso Bionics this week, compared to 3 articles on an average week.Search Interest2 people have searched for EKSO on MarketBeat in the last 30 days. MarketBeat Follows3 people have added Ekso Bionics to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ekso Bionics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.05% of the stock of Ekso Bionics is held by insiders.Percentage Held by InstitutionsOnly 12.74% of the stock of Ekso Bionics is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Ekso Bionics is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ekso Bionics is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEkso Bionics has a P/B Ratio of 0.55. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Ekso Bionics (NASDAQ:EKSO) StockEkso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.Read More Receive EKSO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address EKSO Stock News HeadlinesMarch 31, 2023 | marketwatch.comHealthcare Assistive Robot Market 2023 Growth, Trend and Outlook till 2031March 31, 2023 | americanbankingnews.comEkso Bionics (NASDAQ:EKSO) Coverage Initiated by Analysts at StockNews.comMarch 31, 2023 | Legacy Research (Affiliate) (Ad)Sell every Stock except ONE Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...March 30, 2023 | marketwatch.comMedical Robotics Market Updates with SizeMarch 29, 2023 | finanznachrichten.deEkso Bionics Holdings, Inc.: Ekso Bionics Reports Fourth Quarter and Year End 2022 ResultsMarch 28, 2023 | msn.comEkso Bionics Holdings GAAP EPS of -$0.24, revenue of $3.55MMarch 28, 2023 | finance.yahoo.comEkso Bionics Reports Fourth Quarter and Year End 2022 ResultsMarch 27, 2023 | marketwatch.comHealthcare Wearable Robot Market Share, Size, Financial Summaries Analysis from 2023-2029 | Bionik, ATOUN, Ekso BionicsMarch 31, 2023 | Legacy Research (Affiliate) (Ad)Sell every Stock except ONE Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...March 27, 2023 | markets.businessinsider.comWhat Wall Street expects from Ekso Bionics's earningsMarch 27, 2023 | americanbankingnews.comEkso Bionics (EKSO) Set to Announce Earnings on TuesdayMarch 24, 2023 | marketwatch.comIntelligent Artificial Limb Market Share By 2031March 23, 2023 | marketwatch.comGlobal Wearable Artificial Organs Market: Future Extrapolations and Emerging Updates for 2023-2027March 22, 2023 | americanbankingnews.comEkso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.comMarch 21, 2023 | marketwatch.comRobotic Exoskeleton Market Key Vendors and Forecast till 2028March 20, 2023 | marketwatch.comBionic Devices Market Outlook and Forecast till 2028March 20, 2023 | marketwatch.com2023-2029 Robotics for Physical Therapy Market Share and Growth Insights | Latest Research ReportMarch 20, 2023 | finance.yahoo.comEkso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023March 19, 2023 | marketwatch.comMedical Robot Market Top Players and Forecast till 2028March 16, 2023 | marketwatch.comRehabilitation Robots Market to 2023-2029March 16, 2023 | marketwatch.comHumanoid Healthcare Assistive Robot Market Share and Forecast till 2028March 15, 2023 | marketwatch.comSocially Assistive Healthcare Assistive Robot Market Size, Growth | Soaring Demand | 2023 - 2029March 15, 2023 | marketwatch.comExoskeleton Market Application, Product, Sales and Forecast 2023-2028March 15, 2023 | marketwatch.comWearable Robot Market Application, Product, Sales and Forecast 2023-2028March 15, 2023 | marketwatch.comHome Rehabilitation Market Size, Trends Analysis and Revenue Generation to 2028March 15, 2023 | marketwatch.comHome Rehabilitation Products and Services Market Application, Product, Sales and Forecast 2023-2028March 14, 2023 | marketwatch.com2023-2029 Medical Exoskeletons Market Size, Gross Margin and Revenue Analysis | Research Report by Absolute ReportsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive EKSO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address EKSO Company Calendar Last Earnings11/01/2021Today3/31/2023Next Earnings (Estimated)4/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry General industrial machinery, Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:EKSO Previous SymbolOTCMKTS:EKSOD CUSIPN/A CIK1549084 Webwww.eksobionics.com Phone(510) 984-1761Fax510-927-2647Employees55Year FoundedN/APrice Target and Rating Average Stock Price Forecast$9.00 High Stock Price Forecast$9.00 Low Stock Price Forecast$9.00 Forecasted Upside/Downside+484.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,760,000.00 Net Margins-109.88% Pretax Margin-109.88% Return on Equity-45.07% Return on Assets-34.09% Debt Debt-to-Equity RatioN/A Current Ratio4.68 Quick Ratio4.23 Sales & Book Value Annual Sales$11.25 million Price / Sales1.80 Cash FlowN/A Price / Cash FlowN/A Book Value$2.94 per share Price / Book0.52Miscellaneous Outstanding Shares13,140,000Free Float12,741,000Market Cap$20.24 million OptionableNot Optionable Beta1.75 Key ExecutivesScott DavisPresident, Chief Executive Officer & DirectorJason JonesChief Operating OfficerJerome WongChief Financial Officer, Secretary & ControllerRino BevisDirector-Commercial HealthCharlie WuSenior Director-OperationsKey CompetitorsAcasti PharmaNASDAQ:ACSTVaccinexNASDAQ:VCNXMonopar TherapeuticsNASDAQ:MNPRCyclerion TherapeuticsNASDAQ:CYCNInhibikase TherapeuticsNYSE:IKTView All CompetitorsInsiders & InstitutionsSusquehanna International Group LLPSold 13,900 shares on 2/14/2023Ownership: 0.000%Essex Investment Management Co. LLCBought 124,384 shares on 2/3/2023Ownership: 3.379%Simplex Trading LLCSold 11,100 shares on 2/2/2023Ownership: 0.000%Legato Capital Management LLCBought 37,497 shares on 2/1/2023Ownership: 0.285%Strategic Wealth Investment Group LLCBought 5,917 shares on 1/27/2023Ownership: 0.216%View All Insider TransactionsView All Institutional Transactions EKSO Stock - Frequently Asked Questions Should I buy or sell Ekso Bionics stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" EKSO shares. View EKSO analyst ratings or view top-rated stocks. What is Ekso Bionics' stock price forecast for 2023? 1 brokerages have issued 1-year price objectives for Ekso Bionics' shares. Their EKSO share price forecasts range from $9.00 to $9.00. On average, they anticipate the company's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 484.4% from the stock's current price. View analysts price targets for EKSO or view top-rated stocks among Wall Street analysts. How have EKSO shares performed in 2023? Ekso Bionics' stock was trading at $1.19 at the beginning of the year. Since then, EKSO stock has increased by 29.4% and is now trading at $1.54. View the best growth stocks for 2023 here. When is Ekso Bionics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023. View our EKSO earnings forecast. How were Ekso Bionics' earnings last quarter? Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) issued its quarterly earnings data on Monday, November, 1st. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.10. The business earned $3.05 million during the quarter, compared to the consensus estimate of $2.58 million. Ekso Bionics had a negative net margin of 109.88% and a negative trailing twelve-month return on equity of 45.07%. During the same period in the previous year, the business posted ($0.52) earnings per share. When did Ekso Bionics' stock split? Ekso Bionics shares reverse split on the morning of Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 4th 2016. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. What other stocks do shareholders of Ekso Bionics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ekso Bionics investors own include Organigram (OGI), Gran Tierra Energy (GTE), KushCo (KSHB), CNBX Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Bionano Genomics (BNGO), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI) and ADMA Biologics (ADMA). What is Ekso Bionics' stock symbol? Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO." Who are Ekso Bionics' major shareholders? Ekso Bionics' stock is owned by a variety of institutional and retail investors. Top institutional investors include Essex Investment Management Co. LLC (3.38%), Legato Capital Management LLC (0.29%), Strategic Wealth Investment Group LLC (0.22%), Simplex Trading LLC (0.00%), Susquehanna International Group LLP (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Jason C Jones, Jerome Wong, John Glenn, Scott G Davis and Steven Sherman. View institutional ownership trends. How do I buy shares of Ekso Bionics? Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Ekso Bionics' stock price today? One share of EKSO stock can currently be purchased for approximately $1.54. How much money does Ekso Bionics make? Ekso Bionics (NASDAQ:EKSO) has a market capitalization of $20.24 million and generates $11.25 million in revenue each year. The company earns $-9,760,000.00 in net income (profit) each year or ($1.15) on an earnings per share basis. How can I contact Ekso Bionics? Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The official website for the company is www.eksobionics.com. The company can be reached via phone at (510) 984-1761, via email at investors@eksobionics.com, or via fax at 510-927-2647. This page (NASDAQ:EKSO) was last updated on 3/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.